FDA Inspection 1232448 — BioSpectra, Inc.
The FDA completed an inspection of BioSpectra, Inc. on February 2, 2024 in Bangor, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 2, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Bangor, PA (United States)